Seqster Company Overview
Seqster is a healthcare technology company that focuses on making it quick and easy for anyone to have real-time access to their health data. The company's leading service is an enterprise operating system aggregating disparate health data sources into a single, comprehensive view of a patient in real-time. Seqster has partnered with Atropos Health to address historical diversity and inclusion challenges in clinical trials. Seqster has raised $16 million with investors that include OmniHealth Holdings LLC, Takeda Digital Ventures, and 23andMe's CEO and Founder, Anne Wojcicki.
Seqster Valuation History
Seqster Stock Price
The stock price of Seqster can be calculated by taking the valuation of the company divided by the number of shares outstanding. Because a private company can issue new shares at any time, we do not know the current number of shares outstanding.
For illustrative purposes, however, assuming Seqster has issued 250 million shares, at the estimated UpMarket valuation of $39.28 million, each share of Seqster stock would be worth $0.16.
Buy Seqster Stock
If you would like to buy shares in Seqster, please provide your information in the form at the top of this page and click the button titled “I want to buy this stock.”
One of our investor relations team members will contact you to discuss Seqster stock availability. Note: inquiries are non-binding and shares may only be purchased by accredited investors that meet all eligibility criteria.
UpMarket has offered many similar companies as Pre-IPO investments, including Airbnb, SpaceX, ByteDance, Plaid, Kraken, Databricks, and others. UpMarket also often has funds available that invest in a portfolio of companies potentially including, Seqster as well.
Seqster Management
Name | Position |
---|---|
ARDY ARIANPOUR | CEO |
XIANG (SEAN) LI | CTO |